Explore
🏠 Home ⚙️ Dashboard 🔍 Explore 📈 Funds 🏢 AMC 🏭 Companies 📊 Sectors
Tools
🎯 Goal Planner 🔄 Fund Overlap 🧮 SIP Calculator ⏳ SWP Calculator 📊 Similar Funds
Health Care

GLENMARK PHARMACEUTICALS LTD

Analyze mutual fund ownership, AMC exposure and portfolio concentration for GLENMARK PHARMACEUTICALS LTD.

185
Funds Holding
215.89%
Total Exposure

📊 Quick Summary Of This Page

GLENMARK PHARMACEUTICALS LTD is held by multiple mutual funds across India, making it an important institutional holding. Analyze fund ownership patterns, exposure levels and investment concentration across AMCs.
🏆
Top Mutual Fund Owners
185
Mutual funds currently holding this company.
📈
Portfolio Exposure
215.89%
Combined exposure across funds.
🏦
Participating AMCs
15
Asset management companies.
🔥 Top Funds With Highest Exposure
#1
Mirae Asset Healthcare Fund - Direct Plan MIRAEASSET
5.53%
#2
Tata Nifty MidSmall Healthcare Index Fund - Direct Plan TATA
5.14%
#3
Motilal Oswal Nifty MidSmall Healthcare Index Fund - Direct Plan MOTILALOSWAL
5.13%
#4
Bandhan Focused Fund - Direct Plan BANDHAN
4.87%
#5
Bandhan Healthcare Fund - Direct Plan BANDHAN
3.50%
#6
Baroda BNP Paribas Health and Wellness Fund - Direct Plan BARODABNPPARIBAS
3.44%
#7
ICICI Prudential Nifty Pharma Index Fund - Direct Plan ICICIPrudential
3.40%
#8
Motilal Oswal BSE Midcap 150 Momentum 30 Index Fund - Direct Plan MOTILALOSWAL
3.40%
#9
DSP Nifty Healthcare Index Fund - Direct Plan DSP
2.92%
#10
Bank of India Business Cycle Fund - Direct Plan BANKOFINDIA
2.91%
🏆 Category Exposure
Sectoral/Thematic 41.90%
Arbitrage 18.56%
Mid Cap 16.56%
Large & Mid Cap 10.52%
Aggressive 5.49%
ELSS 5.48%
Focused 4.87%
Dynamic Asset Allocation 4.23%
Multi Cap 3.93%
Equity Savings 3.88%
🔗 Similar Companies
SUN PHARMACEUTICAL INDUSTRIES LTD
APOLLO HOSPITALS ENTERPRISE LTD
TORRENT PHARMACEUTICALS LTD
CIPLA LTD
DIVI''S LABORATORIES LTD
FORTIS HEALTHCARE LTD
AUROBINDO PHARMA LTD
LUPIN LTD
BIOCON LTD
AJANTA PHARMA LTD
ALKEM LABORATORIES LTD
ZYDUS LIFESCIENCES LTD
ABBOTT INDIA LTD
DR LAL PATH LABS LTD
NEULAND LABORATORIES LTD
GLAXOSMITHKLINE PHARMACEUTICALS LTD
SYNGENE INTERNATIONAL LTD
ASTER DM QUALITY CARE LTD
ERIS LIFESCIENCES LTD
NARAYANA HRUDAYALAYA LTD
🏦 Top AMC Owners
25.12%
14.37%
13.35%
13.02%
12.86%
12.19%
11.31%
10.42%
10.38%
9.33%
📊 Ownership Insights

GLENMARK PHARMACEUTICALS LTD is currently held by 185 mutual funds with a combined exposure of 215.89% .

The top 10 mutual funds together account for approximately 40.24% portfolio weight in this company.

This stock is most actively owned by 15 AMCs across multiple mutual fund categories.

🚀 Continue Your Research

Compare Funds Similar Funds Historical SIP Explore Hub
🚀 Explore The Complete Mutual Fund Universe
Discover top-ranked mutual funds, compare schemes, analyze portfolio holdings, explore AMCs, identify category leaders and use powerful investment planning tools — all from one place.
⭐ Top Ranked Funds 🏆 Category Leaders 🏢 AMC Insights 📈 Popular Stocks 🛠 Planning Tools 🔍 Similar Funds
Explore CheckPAN
Browse 7,500+ mutual funds, leading AMCs, portfolio companies and investment insights.
Frequently Asked Questions

This page shows mutual funds that currently invest in GLENMARK PHARMACEUTICALS LTD, along with their exposure and allocation percentage.

Mutual funds invest in GLENMARK PHARMACEUTICALS LTD based on factors such as financial performance, growth potential, valuation and sector outlook.

Mutual fund exposure to GLENMARK PHARMACEUTICALS LTD represents the total percentage of holdings across all mutual fund portfolios combined.

High mutual fund holding in GLENMARK PHARMACEUTICALS LTD indicates institutional interest, but it should be analyzed along with fundamentals and market conditions.

Yes, mutual funds frequently adjust their holdings in GLENMARK PHARMACEUTICALS LTD based on market conditions and investment strategy.

Multiple AMCs may invest in GLENMARK PHARMACEUTICALS LTD depending on their fund strategy, sector allocation and risk profile.

GLENMARK PHARMACEUTICALS LTD belongs to a specific industry sector which influences its inclusion in mutual fund portfolios.

Yes, you can track changes in mutual fund holdings of GLENMARK PHARMACEUTICALS LTD whenever new portfolio disclosures are released.

Mutual fund ownership can influence liquidity and demand, but stock price is affected by multiple market and business factors.

You can analyze institutional investment in GLENMARK PHARMACEUTICALS LTD by reviewing mutual fund holdings, allocation trends and ownership concentration.
© 2026 CheckPan